EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Lung transplantation for pulmonary alveolar proteinosis: a retrospective international multicentre analysis

Stefan Schwarz, Helmut Prosch iD, Erdal Yekeler, Piergiorgio Solli, Xavier Demant, Don Hayes, Masayuki Chida, Kieran Halloran, Mark Greer iD, Puneet Garcha, Laurens J Ceulemans, Sandra Lindstedt und 25 weitere

European Respiratory Journal · 2026

DOI: 10.1183/13993003.02351-2025 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Respiratory Journal, 2026. Verfasst von Stefan Schwarz und 36 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Comprehensive Center for Chest Diseases, Medical University of Vienna, Vienna, Austria stefan.a.schwarz@meduniwien.ac…. Hauptthemen laut MEDLINE: Pulmonary Alveolar Proteinosis, Lung Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary alveolar proteinosis (PAP) is a rare disease. Only a small number of case reports describing lung transplantation (LTx) as a treatment option for PAP have been published. Due to this limited evidence, current guidelines on LTx for PAP remain vague. To address this gap, we collected cases of LTx for PAP worldwide.

Methods

214 centres were approached to contribute any cases of LTx performed for PAP. Re-transplantations and multi-organ transplantations were excluded. Patients were divided into two groups based on the presence of PAP recurrence after LTx. Time-to-event analyses were performed using Kaplan–Meier curves and Cox proportional-hazards modelling was performed with PAP recurrence as a time-dependent covariate.

Results

At a response rate of 64%, 31 centres contributed 63 patients. Most had primary PAP (n=20; 39.2%). Six patients with secondary PAP were identified (11.8%), while seven (13.7%) had congenital and 18 (35.3%) unclassified PAP. Aetiology was not specified in 12. Patients underwent transplantation at a median (interquartile range) 11 (3–17) years after initial diagnosis. Nine (15%) patients developed PAP recurrence after LTx. No significant difference was found regarding patient characteristics between the patients with versus without recurrence. Freedom from recurrence was 96.2% (1 year), 83.5% (5 years) and 70.1% (10 years) post-LTx. PAP recurrence as time-dependent covariate was not significantly associated with graft loss (hazard ratio 1.88, 95% CI 0.51–6.91; p=0.342) in a Cox proportional-hazards model.

Conclusion

LTx provides excellent peri-operative and long-term outcomes for patients with end-stage PAP and should be recommended in treatment guidelines. Although recurrence of PAP occurs in ∼15% of cases, overall survival appeared unaffected in our limited dataset.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Alveolar ProteinosisLung TransplantationHumansFemaleRetrospective StudiesProportional Hazards ModelsRecurrenceMaleKaplan-Meier EstimateAdultTreatment OutcomeMiddle AgedAdolescentYoung Adult

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Comprehensive Center for Chest Diseases, Medical University of Vienna, Vienna, Austria stefan.a.schwarz@meduniwien.ac.at.
  • Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Department of Thoracic Surgery and Lung Transplantation, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
  • Department of Cardio-Thoracic Surgery and Heart and Lung Transplantation, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Service de Pneumologie et Transplantation Pulmonaire, CHU de Bordeaux, Bordeaux, France.
  • Heart Institute and Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

ORCID-Profile: Helmut Prosch, Mark Greer, Robert M Reed, David M Sayah, Victor M Mora, Jesper M Magnusson, Kinan El Husseini, Alberto Benazzo, Clemens Aigner, Francesco Bonella, Peter Jaksch

Zitieren

APA

Schwarz, S., Prosch, H., Yekeler, E., Solli, P., Demant, X., Hayes, D., Chida, M., Halloran, K., Greer, M., Garcha, P., Ceulemans, L. J., Lindstedt, S., Merveilleux, C., Reed, R. M., Musk, M., Shtraichman, O., Sanchez, P. G., Abdulqawi, R., Sayah, D. M., …, & Hoetzenecker, K. (2026). Lung transplantation for pulmonary alveolar proteinosis: a retrospective international multicentre analysis. European Respiratory Journal. https://doi.org/10.1183/13993003.02351-2025

Vancouver

Schwarz S, Prosch H, Yekeler E, Solli P, Demant X, Hayes D, et al. Lung transplantation for pulmonary alveolar proteinosis: a retrospective international multicentre analysis. European Respiratory Journal. 2026. doi:10.1183/13993003.02351-2025

BibTeX
@article{Schwarz2026,
  author = {Schwarz, Stefan and Prosch, Helmut and Yekeler, Erdal and Solli, Piergiorgio and Demant, Xavier and Hayes, Don and Chida, Masayuki and Halloran, Kieran and Greer, Mark and Garcha, Puneet and Ceulemans, Laurens J and Lindstedt, Sandra and Merveilleux, Claire and Reed, Robert M and Musk, Michael and Shtraichman, Osnat and Sanchez, Pablo G and Abdulqawi, Rayid and Sayah, David M and Mora, Victor M and Magnusson, Jesper M and Balaguer Cartagena, María Nieves and Zapata Gonzalez, Ricardo A and Fisher, Andrew J and Rosado, Joel and Osses, Juan M and Koch, Achim and Reynolds, John M and Picard, Clement and El Husseini, Kinan and Aversa, Meghan and Kaza, Vaidehi and Benazzo, Alberto and Aigner, Clemens and Bonella, Francesco and Jaksch, Peter and Hoetzenecker, Konrad},
  title = {Lung transplantation for pulmonary alveolar proteinosis: a retrospective international multicentre analysis},
  journal = {European Respiratory Journal},
  year = {2026},
  doi = {10.1183/13993003.02351-2025}
}
Kostenlos starten →